← Leaderboards
Joaquim Gascon
University Of Texas El Paso
$2,573,277
Attributed
$7,719,832
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–24$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,719,832 · 1
By mechanism
U01$7,719,832 · 1
Top collaborators
- Igor C Almeida7 shared
- Faustino Torrico7 shared
Most similar at University Of Texas El Paso
Same institution · by research overlap
- Igor C Almeida$7,605,257
- Faustino Torrico$2,573,277
- Rosa A Maldonado$4,365,494
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAdverse Drug EventAdverse EventAffectAftercareAnimalsAntibodiesAntigensAntioxidantsAntiparasitic AgentsAppearanceAptamerBenznidazoleBiological MarkersBloodCardiomyopathiesChagas DiseaseChemotherapyChemotherapy-Oncologic ProcedureChildChronicChronic InfectionChronic PhaseAcute
Grant awards (7)
New chemotherapy regimens and biomarkers for Chagas disease$739,415
U01 · FY2024 · AI
New chemotherapy regimens and biomarkers for Chagas disease$916,180
U01 · FY2023 · AI
New chemotherapy regimens and biomarkers for Chagas disease$1,214,881
U01 · FY2022 · AI
New chemotherapy regimens and biomarkers for Chagas disease$1,234,359
U01 · FY2021 · AI
New chemotherapy regimens and biomarkers for Chagas disease$1,248,620
U01 · FY2020 · AI
New chemotherapy regimens and biomarkers for Chagas disease$1,184,499
U01 · FY2019 · AI
New chemotherapy regimens and biomarkers for Chagas disease$1,181,878
U01 · FY2018 · AI